- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 4/00 - Peptides having up to 20 amino acids in an undefined or only partially defined sequenceDerivatives thereof
Patent holdings for IPC class C07K 4/00
Total number of patents in this class: 452
10-year publication summary
|
39
|
26
|
32
|
30
|
22
|
8
|
18
|
15
|
18
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19918 |
13 |
| Ambrx, Inc. | 181 |
6 |
| Emulate, Inc. | 221 |
6 |
| The University of Chicago | 1406 |
5 |
| Centre National de La Recherche Scientifique | 10418 |
4 |
| The United States of America as represented by the Secretary of the Navy | 2745 |
4 |
| The Regents of the University of Michigan | 4698 |
4 |
| Idemitsu Kosan Co., Ltd. | 4219 |
4 |
| President and Fellows of Harvard College | 5976 |
4 |
| Duke University | 3066 |
4 |
| Aileron Therapeutics, Inc. | 80 |
4 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2157 |
4 |
| Genequantum Healthcare (Suzhou) Co., Ltd. | 63 |
4 |
| FUJIFILM Corporation | 29367 |
3 |
| The General Hospital Corporation | 4733 |
3 |
| Ajinomoto Co., Inc. | 2295 |
3 |
| Agency for Science, Technology and Research | 3620 |
3 |
| The Board of Trustees of the University of Illinois | 2688 |
3 |
| AC Immune S.A. | 262 |
3 |
| bioMerieux | 921 |
3 |
| Other owners | 365 |